January 29, 2020

Intercept Completes Phase 3 Enrollment of Cirrhosis Treatment

Intercept has completed patient enrollment in its Phase 3 study evaluating obeticholic acid for the treatment of cirrhosis due to...
January 2, 2020

Biotech Outlook 2020: Washington Scrutiny Looms Over Sector

INN offers a closer look at the path ahead for biotech investors in 2020 as new challenges arise for the...
October 16, 2019

Biotech Market Update: Q3 2019 in Review

With Q3 2019 officially over, the Investing News Network shares a biotech market update on the biggest news and trends...